Month: February 2024

Expands assortment of potted and fresh-cut herbs and services BELVIDERE, NJ, Feb. 12, 2024 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that the Company has signed 3-year agreements with a major U.S. food retailer to service, develop and expand the retailer’s current Edible Garden product assortment. Mr. Jim Kras, Chief Executive Officer of Edible Garden, stated, “We are excited to expand our relationship with this retailer, which will allow us to broaden the product range within their retail store locations. Products that will be added to an already robust offering will include both potted and fresh-cut herbs, fresh-cut basil, and wheatgrass....

SAN CLEMENTE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced the appointment of James Bartholomeusz to the newly created position of Chief Innovation Officer. Mr. Bartholomeusz is a medical aesthetics expert and industry veteran with more than 20 years of experience. He will lead global product innovation, development, and go-to market strategies for new product launches. “We are delighted to have James join Sofwave at this important stage of accelerated growth, product innovation and global expansion. His past leadership and track record in developing and launching new products includes driving the innovation and roll-out of groundbreaking body contouring technologies,...

AUSTIN, Texas, Feb. 12, 2024 (GLOBE NEWSWIRE) — Volcon Inc. (NASDAQ: VLCN) (“Volcon” or the “Company”), the first all-electric, off-road powersports company posted a video to its website providing an update on the Stag launch. A link to the video is posted below:   Stag Update Video Link. About Volcon Based in the Austin, Texas area, Volcon was founded as the first all-electric power sports company producing high-quality and sustainable electric vehicles for the outdoor community. Volcon electric vehicles are the future of off-roading, not only because of their environmental benefits but also because of their near-silent operation, which allows for a more immersive outdoor experience. Volcon’s vehicle roadmap includes both motorcycles and UTVs. Its first product, the innovative Grunt, began shipping to customers in late 2021...

The Iconic Entertainer Will Present A Journey of Love, Music, and Wellness LOS ALAMITOS, Calif. and LAS VEGAS, Feb. 12, 2024 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”) is delighted to announce the launch of an extraordinary livestream shopping series on MARKET.live featuring Frankie Avalon, the entertainer beloved by generations, and co-hosted by the popular TV personality Albany Irvin. The show, the first in a series, is scheduled for Thursday, February 15, at 3 pm PST / 6 pm EST. Show Highlights:Date/Time: Thursday, Feb. 15 at 3 pm PST/6 pm EST Hosts: FRANKIE AVALON, with co-host Albany Irvin (albanyirvin.com) Product: Fruit and Veggie SupplementsShow Theme: A Journey of Love, Music, and Wellness Join Frankie Avalon on a captivating journey through his...

Poster presentation unveils Corvus’ next-generation ITK inhibitor candidates designed to deliver precise T cell modulation for immunology indicationsFigure 1Venn diagram illustrating different biological properties of the next-gen ITK inhibitors in T cell differentiation assays.BURLINGAME, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that preclinical data for soquelitinib, the Company’s lead ITK inhibitor program, was presented in a poster session at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases, which took place February 8-11, 2024. The poster presentation includes the first description of Corvus’ next-generation ITK inhibitor preclinical product candidates, which were designed to deliver...

LOS ANGELES, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — On January 29, 2024, an innovative brain implant company reached a new company milestone by surgically implanting electrodes in the brain of their first human subject, thus signaling the opening of a new age and a new industry for companies such as Grapheton. US Nuclear (OTC-QB: UCLE) is proud to be Grapheton’s partner and largest investor, and is incredibly excited about their potential to revolutionize therapies for disabled people of every sort. Grapheton has developed cutting-edge bioelectronic implants aimed at treating various ailments such as cardiac abnormalities, chronic pain, Parkinson’s disease, and hearing loss, taking their technology a step further by using next-generation carbon-based material and multi-modal probes that read both electrical...

FREMONT, CA , Feb. 12, 2024 (GLOBE NEWSWIRE) — The Company holds a U.S. patent for the same treatment via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that it received an Australian patent, valid until 2040, Application No. 2021314052, for the use of PDC-1421, a Radix Polygala (Polygala tenuifolia Willd) extract, used in the Company’s asset ABV-1504 for the treatment of Major Depressive Disorder (MDD). The Company was previously awarded a U.S. patent, US 11,554,154 B2, on April 25, 2023, for the same treatment. “These patents grant ABVC the right to exclude others from using, offering, or selling PDC-1421 throughout the United States and Australia...